June 2023
1. HARM T, Frey M, Dittrich K, Goldschmied A, et al
   Statin Treatment Is Associated with Alterations in the Platelet Lipidome.
   Thromb Haemost. 2023;123:585-596.
   

   >> Share

   
   
2. SONG H, Ahn JH, Kang MG, Kim KH, et al
   Post-PCI Risk Assessment by Inflammation Activity According to Disease Acuity and Time from Procedure.
   Thromb Haemost. 2023;123:627-640.
   

   >> Share

   
   May 2023
3. GIANNIS D, Goldin M, Rahman H, Sison CP, et al
   Risk factors for post-discharge major thromboembolism and mortality in hospitalized patients with COVID-19 with cardiovascular comorbidities.
   Thromb Haemost. 2023 May 5. doi: 10.1055/a-2087-3003.
   

   >> Share

   
   April 2023
4. CHEN D, Zhao Z, Liu P, Liu X, et al
   Adventitial Vasa Vasorum Neovascularization in Femoral Artery of Type 2 Diabetic Patients with Macroangiopathy Is Associated with Macrophages and Lymphocytes as well as the Occurrence of Cardiovascular Events.
   Thromb Haemost. 2023 Apr 10. doi: 10.1055/s-0043-1768162.
   

   >> Share

   
   March 2023
5. LIU D, Zhang P, Zhang K, Bi C, et al
   Role of GPR56 in Platelet Activation and Arterial Thrombosis.
   Thromb Haemost. 2023;123:295-306.
   

   >> Share

   
   January 2023
6. NICOLAJSEN CWW, Bronnum Nielsen P, Jensen M, Eldrup N, et al
   Stroke and myocardial infarction in patients with abdominal aortic aneurysms and new-onset atrial fibrillation.
   Thromb Haemost. 2023 Jan 10. doi: 10.1055/a-2009-8954.
   

   >> Share

   
   
7. VERHEUGT FWA, Huber K
   Continuous Improvement of Antiplatelet Therapy in Cardiovascular Disease.
   Thromb Haemost. 2023 Jan 5. doi: 10.1055/s-0042-1760129.
   

   >> Share

   
   
8. PEDERSEN OB, Grove EL, Nissen PH, Larsen SB, et al
   Expression of microRNA Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease.
   Thromb Haemost. 2023 Jan 5. doi: 10.1055/s-0042-1760258.
   

   >> Share

   
   
9. ZHU W, Cao Y, Ye M, Huang H, et al
   Essen Stroke Risk Score Predicts Clinical Outcomes in Heart Failure Patients with Preserved Ejection Fraction: Evidence from the TOPCAT trial.
   Thromb Haemost. 2023;123:85-96.
   

   >> Share

   
   December 2022
10. NILSEN DWT, Roysland M, Ueland T, Aukrust P, et al
    The Effect of Protease-Activated Receptor-1 (PAR-1) Inhibition on Endothelial-Related Biomarkers in Patients with Coronary Artery Disease.
    Thromb Haemost. 2022 Dec 31. doi: 10.1055/s-0042-1760256.
    

    >> Share

    
    
11. VERHEUGT FWA, Huber K, Clemmensen P, Collet JP, et al
    Platelet P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention: An Emerging Option for Antiplatelet Therapy De-escalation.
    Thromb Haemost. 2022 Dec 30. doi: 10.1055/s-0042-1755330.
    

    >> Share

    
    November 2022
12. KOCH T, Lahu S, Coughlan JJ, Cassese S, et al
    Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
    Thromb Haemost. 2022 Nov 28. doi: 10.1055/a-1988-5047.
    

    >> Share

    
    
13. SHAO QY, Wang ZJ, Ma XT, Wang YF, et al
    Mortality of Escalation and Modulation Antithrombotic Therapy in Coronary Artery Disease Patients: A Meta-analysis of Randomized Controlled Trials.
    Thromb Haemost. 2022 Nov 7. doi: 10.1055/s-0042-1757405.
    

    >> Share

    
    October 2022
14. BUCKLEY BJR, Lip GYH
    Current Concepts: Comprehensive "Cardiovascular Health" Rehabilitation-An Integrated Approach to Improve Secondary Prevention and Rehabilitation of Cardiovascular Diseases.
    Thromb Haemost. 2022 Oct 28. doi: 10.1055/s-0042-1757403.
    

    >> Share

    
    
15. ROONGSANGMANOON W, Chichareon P, Angkananard T, Suwannasom P, et al
    External validation of ACUITY/HORIZON bleeding risk score among acute coronary syndrome patients in Thai PCI Registry.
    Thromb Haemost. 2022 Oct 20. doi: 10.1055/a-1964-8247.
    

    >> Share

    
    September 2022
16. GUEANT JL, Gueant-Rodriguez RM, Oussalah A, Zuily S, et al
    Hyperhomocysteinemia in cardiovascular diseases: revisiting observational studies and clinical trials.
    Thromb Haemost. 2022 Sep 28. doi: 10.1055/a-1952-1946.
    

    >> Share

    
    
17. RIKKEN SAOF, Storey RF, Andreotti F, Clemmensen P, et al
    Parenteral Antiplatelet Drugs in ST-Elevation Myocardial Infarction: Current Status and Future Directions.
    Thromb Haemost. 2022 Sep 8. doi: 10.1055/s-0042-1753479.
    

    >> Share

    
    August 2022
18. BAMPATSIAS D, Mavroeidis I, Tual-Chalot S, Vlachogiannis NL, et al
    Beta-secretase-1 antisense RNA is associated with vascular ageing and atherosclerotic cardiovascular disease.
    Thromb Haemost. 2022 Aug 1. doi: 10.1055/a-1914-2094.
    

    >> Share

    
    June 2022
19. NOUMEGNI SR, Mansourati V, Tromeur C, Mao RL, et al
    Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study.
    Thromb Haemost. 2022 Jun 18. doi: 10.1055/s-0042-1748889.
    

    >> Share

    
    
20. ARASHI H, Yamaguchi J, Hagiwara N, Yasuda S, et al
    Rivaroxaban Underdose for Atrial Fibrillation with Stable Coronary Disease: The AFIRE Trial Findings.
    Thromb Haemost. 2022 Jun 13. doi: 10.1055/s-0042-1744543.
    

    >> Share

    
    
21. AKYEA RK, Georgiopoulos G, Iyen B, Kai J, et al
    Comparison of risk of serious cardiovascular events after haemorrhagic versus ischaemic stroke: a population-based study.
    Thromb Haemost. 2022 Jun 10. doi: 10.1055/a-1873-9092.
    

    >> Share

    
    May 2022
22. TASOUDIS P, Kyriakoulis I, Sagris D, Diener HC, et al
    Clopidogrel monotherapy versus Aspirin monotherapy in patients with established cardiovascular disease: systematic review and meta-analysis.
    Thromb Haemost. 2022 May 16. doi: 10.1055/a-1853-2952.
    

    >> Share

    
    
23. ZHANG Y, Zhang Y, Shi X, Lin B, et al
    Clopidogrel versus Ticagrelor in CYP2C19 Loss-of-Function Allele Noncarriers: A Real-World Study in China.
    Thromb Haemost. 2022;122:842-852.
    

    >> Share

    
    April 2022
24. PATTI G, Grisafi L, Spinoni E, Rognoni A, et al
    Safety and efficacy of selective, clopidogrel-based strategies in acute coronary syndrome: a study-level meta-analysis.
    Thromb Haemost. 2022 Apr 18. doi: 10.1055/a-1827-8041.
    

    >> Share

    
    March 2022
25. DEL BIANCO-RONDEAU M, Robert-Halabi M, Bloom S, Rabasa-Lhoret R, et al
    Aspirin for Primary Cardiovascular Prevention in Patients with Diabetes: Uncertainties and Opportunities.
    Thromb Haemost. 2022 Mar 4. doi: 10.1055/s-0042-1743469.
    

    >> Share

    
    
26. MALY M, Riedel T, Stikarova J, Suttnar J, et al
    Incorporation of Fibrin, Platelets, and Red Blood Cells into a Coronary Thrombus in Time and Space.
    Thromb Haemost. 2022;122:434-444.
    

    >> Share

    
    February 2022
27. LOPEZ-GALVEZ R, Rivera-Caravaca JM
    Growth differentiation factor 15 (GDF-15) in cardiovascular diseases: predicting bleeding after cardiac surgery and beyond that!
    Thromb Haemost. 2022 Feb 10. doi: 10.1055/a-1768-4206.
    

    >> Share

    
    
28. NAVARESE EP, Grisafi L, Spinoni EG, Mennuni MG, et al
    Safety and Efficacy of Different Antithrombotic Strategies after Transcatheter Aortic Valve Implantation: A Network Meta-Analysis.
    Thromb Haemost. 2022;122:216-225.
    

    >> Share

    
    January 2022
29. CLELAND JGF
    Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?
    Thromb Haemost. 2022 Jan 20. doi: 10.1055/s-0041-1740639.
    

    >> Share

    
    
30. CANTONI S, Colombo C, Soriano F, Oreglia JA, et al
    RARE CAUSES OF ACUTE CORONARY SYNDROME: THE JAK2 V617F MUTATION POSITIVE MYELOPROLIFERATIVE NEOPLASMS. A cardio-hematological perspective.
    Thromb Haemost. 2022 Jan 17. doi: 10.1055/a-1742-0361.
    

    >> Share

    
    
31. GOROG DA, Massberg S
    NETs in the infarct-related coronary artery - a marker or mediator of adverse outcome?
    Thromb Haemost. 2022 Jan 10. doi: 10.1055/a-1733-9217.
    

    >> Share

    
    
32. CHAO TF, Joung B, Takahashi Y, Lim TW, et al
    2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.
    Thromb Haemost. 2022;122:20-47.
    

    >> Share

    
    November 2021
33. BLASCO A, Coronado MJ, Vela P, Martin P, et al
    Prognostic implications of Neutrophil Extracellular Traps in coronary thrombi of patients with ST-elevation myocardial infarction.
    Thromb Haemost. 2021 Nov 30. doi: 10.1055/a-1709-5271.
    

    >> Share

    
    October 2021
34. BOJIC M, Bielesz B, Cejka D, Schernthaner GH, et al
    Calcification Propensity in Serum and Cardiovascular Outcome in Peripheral Artery Disease.
    Thromb Haemost. 2021 Oct 31. doi: 10.1055/s-0041-1736444.
    

    >> Share

    
    
35. MCCUTCHEON K, Manga P
    Human Immunodeficiency Virus and Cardiovascular Disease: Revisiting the Inflammation-Thrombosis Axis.
    Thromb Haemost. 2021 Oct 24. doi: 10.1055/s-0041-1736445.
    

    >> Share

    
    
36. CALDERONE D, Greco A, Ingala S, Agnello F, et al
    Efficacy and safety of aspirin for cardiovascular risk prevention in younger and older age: an updated systematic review and meta-analysis.
    Thromb Haemost. 2021 Oct 12. doi: 10.1055/a-1667-7427.
    

    >> Share

    
    
37. JEONG YH, Oh JH, Yoon HJ, Park Y, et al
    Pharmacodynamic Profile and Prevalence of Bleeding Episode in East Asian Patients with Acute Coronary Syndromes Treated with Prasugrel Standard-Dose versus De-escalation Strategy: A Randomized A-MATCH Trial.
    Thromb Haemost. 2021;121:1376-1386.
    

    >> Share

    
    July 2021
38. VERA A, Rivero F, Salamanca J, Alvarado-Casas T, et al
    Coronary Plaque Erosion after Abemaciclib Treatment Onset: An Unknown Side Effect?
    Thromb Haemost. 2021;121:976-978.
    

    >> Share

    
    February 2021
39. YAMASHITA A, Nishihira K, Gi T, Maekawa K, et al
    Pathological Features of Ruptured Coronary Plaque and Thrombus Interfaces: Fibrin and von Willebrand Factor as Platelet Scaffolds on Rupture Sites.
    Thromb Haemost. 2021;121:234-241.
    

    >> Share

    
    
40. VAN PARIDON PCS, Panova-Noeva M, van Oerle R, Schulz A, et al
    Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample.
    Thromb Haemost. 2021;121:174-181.
    

    >> Share

    
    January 2021
41. MANDROLA JM, Kaul S, Foy A
    Lessons Learnt from Recent Trials in Ischemic Heart Disease.
    Thromb Haemost. 2021;121:8-14.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share